Clinical Activity, Safety And Tolerability Of Asn002, A Dual Jak/Syk Inhibitor, In Patients With Non-Hodgkin Lymphoma (Nhl), Myeolfibrosis (Mf), Chronic Lymphocytic Leukemia (Cll) And Solid Tumors.
JOURNAL OF CLINICAL ONCOLOGY（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要